Diagnostic Tests for Hepatitis
The essential diagnostic workup for hepatitis includes liver function tests, specific viral markers (serological and molecular), and specialized tests based on the suspected etiology of hepatitis. 1
Initial Laboratory Testing
Liver Function Tests
- Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) - indicate liver cell damage
- Gamma-glutamyl transpeptidase (GGT) and alkaline phosphatase
- Bilirubin (total and direct)
- Serum albumin and gamma globulins
- Complete blood count and prothrombin time
Imaging
- Abdominal hepatic ultrasound is recommended in all patients with suspected hepatitis 2
Viral Hepatitis Testing
Hepatitis A
- Anti-HAV IgM: Diagnostic marker for acute infection
- Anti-HAV IgG: Indicates past infection and immunity 3
Hepatitis B
- Initial panel:
- Additional markers:
- HBeAg and anti-HBe: Determine phase of infection and viral replication
- HBV DNA quantification: Essential for diagnosis, determining infection phase, treatment decisions, and monitoring 2
- HBsAg quantification: Useful for HBeAg-negative chronic infection and patients considered for interferon treatment 2
- HBV genotype: May guide treatment selection and provide prognostic information 2
Hepatitis C
- Initial testing:
- Confirmatory and additional tests:
Hepatitis D
- Only tested in HBsAg-positive patients (requires HBV for replication)
- Anti-HDV IgG: Simplest method for diagnosing delta infection 3
- Anti-HDV IgM and HDV RNA: Indicate active infection 6
Hepatitis E
- Anti-HEV IgM and IgG: For acute infection diagnosis
- HEV RNA: For confirmation of active infection
- HEV antigen: May be used for both acute and chronic infection diagnosis 2
Testing for Autoimmune Hepatitis
- Autoantibodies:
- Additional markers:
- Anti-soluble liver antigen/liver pancreas (SLA/LP)
- Anti-liver cytosol type 1 (LC-1)
- Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) 2
- Other tests:
- Serum IgG levels (typically elevated)
- Liver biopsy (interface hepatitis) 2
Testing for Co-infections and Co-morbidities
- Screen for co-infections: HBV/HCV, HBV/HDV, HIV 2, 1
- Test for immunity to HAV in patients with chronic liver disease 7
- Evaluate for other causes of liver disease:
- Alcoholic liver disease
- Metabolic liver disease with steatosis or steatohepatitis
- Other autoimmune conditions 2
Special Considerations
Non-invasive fibrosis assessment:
- Transient elastography (FibroScan)
- Serum biomarkers of liver fibrosis 2
Liver biopsy indications:
- Unclear etiology after initial workup
- Suspected autoimmune hepatitis
- Assessment of disease severity/fibrosis
- Steroid-refractory cases 1
Occult HBV infection testing:
- Consider in cryptogenic liver disease, especially if anti-HBc positive
- Before immunosuppression due to potential for hepatitis flares
- In solid organ transplant donors whose only serological marker of HBV infection is anti-HBc 2
Pitfalls and Caveats
- Serological testing alone for HEV is not sufficiently robust; combine with HEV NAT for accurate diagnosis 2
- Transient elastography results may be confounded by severe inflammation with high ALT levels 2
- False negative HEV RNA results can occur due to genetic polymorphisms 2
- Anti-HCV antibodies may take weeks to months to develop after infection; RNA testing is needed for early diagnosis 5
- Isolated total anti-HBc may indicate occult hepatitis B, especially in immunocompromised patients 2
- Diagnostic accuracy of non-invasive methods is better at excluding than confirming advanced fibrosis or cirrhosis 2
By following this comprehensive diagnostic approach, clinicians can accurately identify the type and stage of hepatitis, which is crucial for appropriate management and treatment decisions.